Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V91.1.231.231_231_237PMID 9414289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deletion of 13q14.3 and not 13q12 is the most common genetic abnormality detected in chronic lymphocytic leukemia cells.

  1997cited by this paper
• Successful use of the same slide for consecutive fluorescence in situ hybridization experiments

  1996cited by this paper
• THE RETINOBLASTOMA GENE (RB1) IN ACUTE MYELOID LEUKAEMIA: ANALYSIS OF GENE REARRANGEMENTS, PROTEIN EXPRESSION AND COMPARISON OF DISEASE OUTCOME

  1996influential reference
• Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia.

  1996cited by this paper
• Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia.

  1996cited by this paper
• Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia

  1996cited by this paper
• The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberration in different hematological malignancies.

  1996cited by this paper
• Frequent homozygous deletions of D13S218 on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivation.

  1995cited by this paper
• Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria.

  1995cited by this paper
• 13q deletions in lymphoid malignancies.

  1995cited by this paper
• Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization.

  1995cited by this paper
• Deletion cartography around the D13S25 locus in B cell chronic lymphocytic leukemia and accurate mapping of the involved tumor suppressor gene.

  1995cited by this paper
• A YAC contig map of the human genome.

  1995cited by this paper
• Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes

  1994influential reference
• Molecular cytogenetic analysis of RB-1 deletions in chronic B-cell leukemias.

  1994cited by this paper
• Cytogenetic deletion maps of hematologic neoplasms: Circumstantial evidence for tumor suppressor Loci

  1993cited by this paper
• The consistent 13q14 translocation breakpoint seen in chronic B-cell leukaemia (BCLL) involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene.

  1993cited by this paper
• Evidence for a new tumour suppressor locus (DBM) in human B–cell neoplasia telomeric to the retinoblastoma gene

  1993cited by this paper
• Retinoblastoma gene deletions in b‐cell chronic lymphocytic leukemia

  1992cited by this paper
• Inactivation of the retinoblastoma gene in acute myelogenous leukaemia

  1992cited by this paper
• Molecular Definition of Interstitial Deletions of Chromosome 13 in Leukemic Cells

  1991cited by this paper
• Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia.

  1991cited by this paper
• Deletion of the human retinoblastoma gene in primary leukemias.

  1990cited by this paper
• Catalog of Chromosome Aberrations in Cancer

  1989influential reference
• Catalog of chromosome aberrations in cancer

  1985cited by this paper
• Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14.

  1980cited by this paper

• The E3 ubiquitin ligase RNF6 facilitates the progression of cervical cancer by inhibiting the Hippo/Yap pathway

  2024cites this paper
• RNF6 as an Oncogene and Potential Therapeutic Target—A Review

  2020cites this paper
• Genomic characterization and prognostication applied to a Brazilian cohort of patients with myelofibrosis

  2020cites this paper
• ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling

  2018cites this paper
• Risk definition and management strategies in retinoblastoma: current perspectives

  2015cites this paper
• Genomic and Clinicopathologic Features of Primary Myelofibrosis With Isolated 13q Deletion.

  2015cites this paper
• Chronic Myeloproliferative Neoplasms

  2015cites this paper
• The double life of KLF5: Opposing roles in regulation of gene‐expression, cellular function, and transformation

  2013cites this paper
• Groupe Français de Cytogénétique Hématologique the chromosomal changes affecting 6 major targets: a study of 21 cases by DC2 acute leukemia is characterized by recurrent clonal + , CD56 + CD4

  2012cites this paper
• Simultaneous Occurrence of Biphenotypic T Cell/Myeloid Lesions Involving t(12;13)(p13;q14) in a Pediatric Patient

  2012cites this paper
• del(13q) in non-Hodgkin's lymphoma

  2011cites this paper
• Gene expression and single nucleotide polymorphism array analyses of spindle cell lipomas and conventional lipomas with 13q14 deletion

  2011cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2011cites this paper
• Evaluation of 13q14 status in patients with chronic lymphocytic leukemia using single nucleotide polymorphism-based techniques.

  2009cites this paper
• Conventional cytogenetics in myelofibrosis: literature review and discussion

  2009cites this paper
• Investigating the Targets of MIR-15a and MIR-16-1 in Patients with Chronic Lymphocytic Leukemia (CLL)

  2009cites this paper
• Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs)

  2008cites this paper
• The 13q and 11q B‐cell chronic lymphocytic leukaemia‐associated regions derive from a common ancestral region in the zebrafish

  2007cites this paper
• Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?

  2007cites this paper
• [Cytogenetics and molecular genetics in myelofibrosis with myeloid metaplasia and polycythemia vera].

  2007cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2007cites this paper
• Tumor suppressor functions of ARLTS1 in lung cancers.

  2007cites this paper
• Cytogénétique et génétique moléculaire dans la myélofibrose avec métaplasie myéloïde et dans la polyglobulie de Vaquez

  2007cites this paper
• Expressió de ZAP-70 en linfòcits B normals i síndromes limfoproliferatives B

  2006cites this paper
• Chromosome aberrations including der(6)t(2;6)(p15;p21.3) and der(22)t(3;22)(p21;p11) in the evolution of essential thrombocythemia to myelofibrosis with myeloid metaplasia.

  2006cites this paper
• Chromosomal abnormalities and molecular markers in myeloproliferative disorders.

  2005cites this paper
• Familial cancer associated with a polymorphism in ARLTS1.

  2005cites this paper
• A der(13)t(7;13)(p13;q14) with monoallelic loss of RB1 and D13S319 in myelodysplastic syndrome.

  2005cites this paper
• Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity.

  2005cites this paper
• Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia.

  2005cites this paper
• Cytogenetics of Myeloproliferative Disorders

  2004cites this paper
• Anomalies chromosomiques dans les leucémies aiguës myéloïdes

  2003cites this paper
• One allele deletion of the RB1 gene in a case of refractory anemia with del(13)(q12q14): a fluorescence in situ hybridization study of the RB1 gene.

  2003cites this paper
• Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis

  2003cites this paper
• Molecular mechanisms of myelodysplastic syndrome.

  2003cites this paper
• [Biologic and clinical relevance of cytogenetic analysis in primary myelodysplastic syndromes].

  2003cites this paper
• Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression.

  2003cites this paper
• [Chromosomal abnormalities in acute myeloid leukaemias].

  2003cites this paper
• Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?

  2003cites this paper
• Place de la cytogénétique dans la prise en charge des syndromes myélodysplasiques primaires

  2003cites this paper
• Cytogenetic and Molecular Genetic Aspects of Idiopathic Myelofibrosis

  2002cites this paper
• Molecular pathogenesis of MDS

  2002cites this paper
• CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique.

  2002cites this paper
• Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 gene.

  2002cites this paper
• CD4 (cid:1) , CD56 (cid:1) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Franc¸ais de Cytoge´ne´tique He´matologique

  2002cites this paper
• Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.

  2001cites this paper
• Myelodysplastic Syndromes Myelodysplastic syndromes : recent advances

  2001cites this paper
• Frequent gain of chromosome 19 in megakaryoblastic leukemias detected by comparative genomic hybridization

  2001cites this paper
• Cytogenetics of chronic myeloid leukaemia.

  2001cites this paper
• Multicolor FISH in chronic lymphocytic leukemia. An interphase study of patients with early-onset disease.

  2001cites this paper
• Myelodysplastic syndromes: recent advances.

  2001cites this paper
• Deletion of chromosomal region 13q14.3 in childhood acute lymphoblastic leukemia

  2001cites this paper
• Myeloproliferative disorders.

  2001cites this paper
• Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia

  2001cites this paper
• Fluorescence in situ hybridization analysis of 25 cases of idiopathic myelofibrosis and two cases of secondary myelofibrosis: monoallelic loss of RB1, D13S319 and D13S25 loci associated with cytogenetic deletion and translocation involving 13q14

  2001cites this paper
• Complex karyotype and N-RAS point mutation in a case of acute megakaryoblastic leukemia (M7) following a myelodysplastic syndrome.

  2000cites this paper
• Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions.

  2000cites this paper
• Non‐random involvement of chromosome 13 in patients with persistent or relapsed disease after bone‐marrow transplantation for chronic myeloid leukemia

  2000cites this paper
• Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome

  2000cites this paper
• Polysomy 13 with concomitant deletion of 13q13-14 involving the retinoblastoma gene and the D13S25 locus in a case of acute myeloid leukemia.

  2000cites this paper
• Frequent allelic loss of the RB, D13S319 and D13S25 locus in myeloid malignancies with deletion/translocation at 13q14 of chromosome 13, but not in lymphoid malignancies

  1999cites this paper
• 13q14 deletion in non-Hodgkin's lymphoma: correlation with clinicopathologic features.

  1999cites this paper
• Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines.

  1999cites this paper
• Cloning and characterization of RNF6, a novel RING finger gene mapping to 13q12.

  1999cites this paper
• Myeloid‐ and lymphoid‐specific breakpoint cluster regions in chromosome band 13q14 in acute leukemia

  1999cites this paper
• Pathogenesis of Idiopathic Myelofibrosis: A Review.

  1998cites this paper
• Pathogenesis and management of idiopathic myelofibrosis.

  1998cites this paper
• Molecular features of primary MDS with cytogenetic changes.

  1998cites this paper
• 3 Pathogenesis and management of idiopathic myelofibrosis

  1998cites this paper
• 7 Molecular genetics and cytogenetics of myeloproliferative disorders

  1998cites this paper
• Molecular genetics and cytogenetics of myeloproliferative disorders.

  1998cites this paper